OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Triple-negative breast cancer: from none to multiple therapeutic targets in two decades
Filomena Marino Carvalho
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Filomena Marino Carvalho
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Showing 12 citing articles:
Prognostic factors of brain metastasis and subsequent survival in breast cancer patients: An 11-year, single-center, retrospective study
Gha-Hyun Lee, Young Mi Seol, Young Jin Choi, et al.
Medicine (2025) Vol. 104, Iss. 11, pp. e41827-e41827
Open Access
Gha-Hyun Lee, Young Mi Seol, Young Jin Choi, et al.
Medicine (2025) Vol. 104, Iss. 11, pp. e41827-e41827
Open Access
Lysyl oxidase-like 4 promotes the invasiveness of triple-negative breast cancer cells by orchestrating the invasive machinery formed by annexin A2 and S100A11 on the cell surface
Tetta Takahashi, Nahoko Tomonobu, Rie Kinoshita, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Tetta Takahashi, Nahoko Tomonobu, Rie Kinoshita, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Nucleic acid vaccines‐based therapy for triple‐negative breast cancer: A new paradigm in tumor immunotherapy arena
Raed Obaid Saleh, Fatma M. Ibrahim, Harikumar Pallathadka, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 3
Raed Obaid Saleh, Fatma M. Ibrahim, Harikumar Pallathadka, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 3
How neutrophils shape the immune response of triple-negative breast cancer: Novel therapeutic strategies targeting neutrophil extracellular traps
Bing Liang, Ye Yuan, Qianheng Jiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117211-117211
Closed Access | Times Cited: 3
Bing Liang, Ye Yuan, Qianheng Jiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117211-117211
Closed Access | Times Cited: 3
Sacituzumab govitecan in triple-negative breast cancer: from bench to bedside, and back
Valentina Rossi, Alessandra Turati, Antonio Rosato, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Valentina Rossi, Alessandra Turati, Antonio Rosato, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
DOCETAXEL VERSUS DOCETAXEL PLUS CAPECITABINE AS NEOADJUVANT CHEMOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER PATIENTS
RAA KHAN, AI MASOOD, Shahid Khan, et al.
Biological and Clinical Sciences Research Journal (2024) Vol. 2024, Iss. 1, pp. 654-654
Open Access | Times Cited: 1
RAA KHAN, AI MASOOD, Shahid Khan, et al.
Biological and Clinical Sciences Research Journal (2024) Vol. 2024, Iss. 1, pp. 654-654
Open Access | Times Cited: 1
Identification of CSNK1D and KLK6 as two common upregulated genes present in BRCA1 mutated triple-negative breast cancer and ovarian epithelial carcinoma
Fatima Lakis, Rita Ayoub, Wissam H. Faour, et al.
Nucleosides Nucleotides & Nucleic Acids (2024), pp. 1-14
Closed Access
Fatima Lakis, Rita Ayoub, Wissam H. Faour, et al.
Nucleosides Nucleotides & Nucleic Acids (2024), pp. 1-14
Closed Access
The comparison between the two most common histological subtypes of breast cancer – invasive ductal and invasive lobular breast carcinoma.
Marta Fudalej, Aleksandra Sobiborowicz, Agata Mormul, et al.
Oncoreview (2024)
Open Access
Marta Fudalej, Aleksandra Sobiborowicz, Agata Mormul, et al.
Oncoreview (2024)
Open Access
MALSU1-mediated regulation of mitochondrial function governs proliferation and doxorubicin resistance in triple-negative breast cancer cells
Feifei Zhuang, Shaoyan Huang, Lei Liu
Molecular and Cellular Biochemistry (2024)
Closed Access
Feifei Zhuang, Shaoyan Huang, Lei Liu
Molecular and Cellular Biochemistry (2024)
Closed Access
Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives
Laura Gilardi, Lighea Simona Airò Farulla, Elena Bonatto, et al.
Current Opinion in Oncology (2024) Vol. 36, Iss. 6, pp. 514-520
Closed Access
Laura Gilardi, Lighea Simona Airò Farulla, Elena Bonatto, et al.
Current Opinion in Oncology (2024) Vol. 36, Iss. 6, pp. 514-520
Closed Access
Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status
Izabela Łaczmańska, Rafał Matkowski, Stanisław Supplitt, et al.
Breast Cancer Research and Treatment (2024) Vol. 208, Iss. 3, pp. 501-510
Open Access
Izabela Łaczmańska, Rafał Matkowski, Stanisław Supplitt, et al.
Breast Cancer Research and Treatment (2024) Vol. 208, Iss. 3, pp. 501-510
Open Access
siRNA Therapeutics: From Bench Lab. to Clinics
Cristina Romero‐López, Alfredo Berzal‐Herranz
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 416-416
Open Access
Cristina Romero‐López, Alfredo Berzal‐Herranz
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 416-416
Open Access
